Three-month change in PSA as a surrogate endpoint for mortality in advanced hormone-refractory prostate cancer (HRPC): Data from Southwest Oncology Group Study S9916

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 4505-4505 ◽  
Author(s):  
E. D. Crawford ◽  
D. K. Pauler ◽  
C. M. Tangen ◽  
M. H. A. Hussain ◽  
E. J. Small ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Surrogate Endpoint ◽  
Hormone Refractory Prostate Cancer ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study ◽  
Hormone Refractory

SWOG-9510: evaluation of topotecan in hormone refractory prostate cancer: A southwest oncology group study

The Prostate ◽  
2002 ◽  
Vol 52 (4) ◽  
pp. 264-268 ◽  
Author(s):  
Catherine E. Klein ◽  
Catherine M. Tangen ◽  
Thomas J. Braun ◽  
Maha H.A. Hussain ◽  
David M. Peereboom ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Hormone Refractory Prostate Cancer ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study ◽  
Hormone Refractory

Doxorubicin, Mitomycin C and 5-Fluorouracil in the Treatment of Hormone Refractory Adenocarcinoma of the Prostate: A Southwest Oncology Group Study

1993 ◽  
Vol 150 (2 Part 1) ◽  
pp. 411-413 ◽  
Author(s):  
Brent Blumenstein ◽  
E. David Crawford ◽  
Joseph H. Saiers ◽  
Ronald L. Stephens ◽  
Saul E. Rivkin ◽  
...  
Keyword(s):  
Mitomycin C ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study ◽  
Adenocarcinoma Of The Prostate ◽  
Hormone Refractory

scholarly journals A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer

2002 ◽  
Vol 13 (3) ◽  
pp. 435-440 ◽  
Author(s):  
C.J. Sweeney ◽  
F.J. Monaco ◽  
S.-H. Jung ◽  
M.J. Wasielewski ◽  
J. Picus ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Hormone Refractory Prostate Cancer ◽  
Estramustine Phosphate ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Hormone Refractory

Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A southwest oncology group study

Cancer ◽  
1993 ◽  
Vol 71 (12) ◽  
pp. 3975-3978 ◽  
Author(s):  
Antoinette J. Wozniak ◽  
Brent A. Blumenstein ◽  
E. David Crawford ◽  
Michael Boileau ◽  
Saul E. Rivkin ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Metastatic Prostate Cancer ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study

Phase II study of platinum and mitoxantrone in metastatic prostate cancer: a Southwest Oncology Group Study

1992 ◽  
Vol 28 (2-3) ◽  
pp. 477-478 ◽  
Author(s):  
C.K. Osborne ◽  
G.R. Weiss ◽  
B.A. Blumenstein ◽  
E.D. Crawford ◽  
R.M. Bukowski ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Phase Ii ◽  
Metastatic Prostate Cancer ◽  
Phase Ii Study ◽  
Oncology Group ◽  
Oncology Group Study ◽  
Southwest Oncology Group ◽  
Southwest Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document